EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Repurposing insights: experimental and pharmacological approach on L-captopril and dimercaprol as metallo-β-lactamase inhibitors

Icíar Rodríguez-Avial, Sthefany Torres, Yuri Puglla, Laura Pérez-Martín, Juan-Luis Sebastianes, Alberto Delgado-Iribarren, Esther Culebras, María-José Valderrama

FEMS Microbiology Letters · 07.01.2026 · 373

DOI: 10.1093/femsle/fnag064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Letters, online erschienen am 30.05.2026. Verfasst von Icíar Rodríguez-Avial und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IdISSC), Servicio de Microbiología Clínica, Instituto Medicina Laboratorio…. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Drug Repositioning, Captopril, Anti-Bacterial Agents. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSIC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design of specific inhibitors of metallo-β-lactamases (MBL) is one of the priority research lines due to the spread of carbapenem resistant bacterial strains which limits therapeutic options. In parallel, the investigation of new uses of known medicines is prompted by regulatory agencies. In this work, the potential MBL inhibitory potency of L-captopril (an antihypertensive drug) and dimercaprol (used in poisoning by metals) was investigated in a clinical collection of Enterobacterales and Pseudomonas spp. In addition, a comprehensive review of the available literature was conducted, to discuss jointly new and previously available data. The results indicate that activity of imipenem and meropenem combined with 400 mg/l is restored for > 80% and 60%, respectively, for Enterobacterales strains, but not in the Pseudomonas group. Dimercaprol had a limited activity in both bacterial groups. Based on these promising results of L-captopril, pharmacological calculations were performed. It is concluded that the repurposing objective could not be achieved as the overall data indicated that the concentrations of captopril required to achieve carbapenemase inhibitory activity in vivo are higher than maximum used in treatment. Communication of negative results would help to discontinue active current research on L-captopril and should focus on other potential MBL inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamase InhibitorsDrug RepositioningCaptoprilAnti-Bacterial AgentsPseudomonasEnterobacteriaceaebeta-LactamasesMicrobial Sensitivity TestsHumansMeropenemImipenem

Stichwörter der Autor:innen

L-captoprilcarbapenem resistancedimercaproldrug repurposingmetallo-β-lactamase

Substanzen

beta-Lactamase InhibitorsCaptoprilbeta-LactamasesAnti-Bacterial AgentsMeropenemImipenem

Autor:innen und Institutionen

  • Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IdISSC), Servicio de Microbiología Clínica, Instituto Medicina Laboratorio (IML), 28040, Madrid, Spain.
  • Department of Medicine, Faculty of Medicine, University Complutense de Madrid, 28040, Madrid, Spain.
  • Department of Genetics, Physiology and Microbiology, Faculty of Biological Sciences, University Complutense de Madrid, 28040, Madrid, Spain.

Förderung

  • CSIC

Zitieren

APA

Rodríguez-Avial, I., Torres, S., Puglla, Y., Pérez-Martín, L., Sebastianes, J. L., Delgado-Iribarren, A., Culebras, E., & Valderrama, M. J. (2026). Repurposing insights: experimental and pharmacological approach on L-captopril and dimercaprol as metallo-β-lactamase inhibitors. FEMS Microbiology Letters, 373. https://doi.org/10.1093/femsle/fnag064

Vancouver

Rodríguez-Avial I, Torres S, Puglla Y, Pérez-Martín L, Sebastianes JL, Delgado-Iribarren A, et al. Repurposing insights: experimental and pharmacological approach on L-captopril and dimercaprol as metallo-β-lactamase inhibitors. FEMS Microbiology Letters. 2026;373. doi:10.1093/femsle/fnag064

BibTeX
@article{RodrguezAvial2026,
  author = {Rodríguez-Avial, Icíar and Torres, Sthefany and Puglla, Yuri and Pérez-Martín, Laura and Sebastianes, Juan-Luis and Delgado-Iribarren, Alberto and Culebras, Esther and Valderrama, María-José},
  title = {Repurposing insights: experimental and pharmacological approach on L-captopril and dimercaprol as metallo-β-lactamase inhibitors},
  journal = {FEMS Microbiology Letters},
  year = {2026},
  volume = {373},
  doi = {10.1093/femsle/fnag064}
}
Kostenlos starten →